These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 21887247)
1. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. Gandapu U; Chaitanya RK; Kishore G; Reddy RC; Kondapi AK PLoS One; 2011; 6(8):e23388. PubMed ID: 21887247 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication. Sunnam LBK; Kondapi AK Mol Biotechnol; 2021 Aug; 63(8):732-745. PubMed ID: 33993458 [TBL] [Abstract][Full Text] [Related]
3. An efficient targeted drug delivery through apotransferrin loaded nanoparticles. Krishna AD; Mandraju RK; Kishore G; Kondapi AK PLoS One; 2009 Oct; 4(10):e7240. PubMed ID: 19806207 [TBL] [Abstract][Full Text] [Related]
4. Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways. Mandraju RK; Kondapi AK Arch Biochem Biophys; 2007 May; 461(1):40-9. PubMed ID: 17391642 [TBL] [Abstract][Full Text] [Related]
5. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes. Kondapi AK; Satyanarayana N; Saikrishna AD Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776 [TBL] [Abstract][Full Text] [Related]
6. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes. Gu J; Al-Bayati K; Ho EA Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051 [TBL] [Abstract][Full Text] [Related]
9. Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats. Golla K; Reddy PS; Bhaskar C; Kondapi AK Drug Deliv; 2013; 20(3-4):156-67. PubMed ID: 23730724 [TBL] [Abstract][Full Text] [Related]
10. Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. Lokeswara Balakrishna S; Satyanarayana N; Kondapi AK Arch Biochem Biophys; 2013 Apr; 532(2):91-102. PubMed ID: 23399433 [TBL] [Abstract][Full Text] [Related]
11. Apotransferrin and holotransferrin undergo different endocytic cycles in intestinal epithelia (Caco-2) cells. Núñez MT; Núñez-Millacura C; Beltrán M; Tapia V; Alvarez-Hernandez X J Biol Chem; 1997 Aug; 272(31):19425-8. PubMed ID: 9235943 [TBL] [Abstract][Full Text] [Related]
12. Molecular docking studies of curcumin natural derivatives with DNA topoisomerase I and II-DNA complexes. Kumar A; Bora U Interdiscip Sci; 2014 Dec; 6(4):285-91. PubMed ID: 25118649 [TBL] [Abstract][Full Text] [Related]
13. Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Dilnawaz F; Singh A; Sahoo SK Acta Biomater; 2012 Feb; 8(2):704-19. PubMed ID: 22051236 [TBL] [Abstract][Full Text] [Related]
14. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin. Muddineti OS; Kumari P; Ghosh B; Biswas S Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866 [TBL] [Abstract][Full Text] [Related]
15. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release. Chen C; Sun W; Wang X; Wang Y; Wang P Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161 [TBL] [Abstract][Full Text] [Related]
16. Self-Monitoring and Self-Delivery of Self-Assembled Fluorescent Nanoparticles in Cancer Therapy. Liu H; Yuan M; Liu Y; Guo Y; Xiao H; Guo L; Liu F Int J Nanomedicine; 2021; 16():2487-2499. PubMed ID: 33824587 [TBL] [Abstract][Full Text] [Related]
17. Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus. González-Molleda L; Wang Y; Yuan Y Antimicrob Agents Chemother; 2012 Feb; 56(2):893-902. PubMed ID: 22106228 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 by curcumin A, a novel curcumin analog. Kumari N; Kulkarni AA; Lin X; McLean C; Ammosova T; Ivanov A; Hipolito M; Nekhai S; Nwulia E Drug Des Devel Ther; 2015; 9():5051-60. PubMed ID: 26366056 [TBL] [Abstract][Full Text] [Related]
19. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems. Tortorella S; Karagiannis TC Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Cui T; Zhang S; Sun H Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]